Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04993651 · ClinicalTrials.gov registry record · NA

Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women

A NA study of Morbid Obesity and Cesarean Delivery Affecting Fetus, sponsored by Eastern Virginia Medical School.

Completed
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT04993651 is a NA study of Morbid Obesity and Cesarean Delivery Affecting Fetus that has completed, run by Eastern Virginia Medical School. The registered enrollment target is 66 participants, below the 119-participant average among 24 other Morbid Obesity trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04993651, a NA study of Morbid Obesity and Cesarean Delivery Affecting Fetus, has completed, sponsored by Eastern Virginia Medical School.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

The objective of our study is to evaluate the effect of CPAP on umbilical cord acid base status in morbidly obese women at the time of scheduled cesarean delivery. We hypothesize that neonates born to mothers wearing CPAP during the cesarean section will have a higher umbilical artery pH.

Interventions

  • DEVICE CPAP

Study Locations (1)

Virginia

  • Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Eastern Virginia Medical School - Norfolk

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2021-10-11
Est. Completion 2023-06-30
Phase NA

Sponsor

Eastern Virginia Medical School

36 total trials

What the Registry Record Tells You About NCT04993651

The ClinicalTrials.gov registry entry for NCT04993651 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 119-participant average among 24 other Morbid Obesity trials with a reported enrollment target (45% lower). The listed sponsor is Eastern Virginia Medical School, which has 36 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Morbid Obesity appearing as the primary indexed condition, and to 1 intervention - of which CPAP is the first listed.

NCT04993651 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT04993651 about?

NCT04993651 is a clinical study titled "Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women". The objective of our study is to evaluate the effect of CPAP on umbilical cord acid base status in morbidly obese women at the time of scheduled cesarean delivery. We hypothesize that neonates born to mothers wearing CPAP during the cesarean section will have a higher umbilical artery pH.

What is the current status of trial NCT04993651?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2021-10-11. Estimated completion is 2023-06-30.

What conditions does trial NCT04993651 study?

This clinical trial studies the following conditions: Morbid Obesity, Cesarean Delivery Affecting Fetus.

What interventions are being tested in trial NCT04993651?

The interventions under investigation include: CPAP (DEVICE).

Who is sponsoring clinical trial NCT04993651?

This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04993651 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Morbid Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.